# Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants

> **NCT03237156** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 24 (actual)

## Conditions studied

- Japanese Healthy Adult Male Participants

## Interventions

- **DRUG:** TAK-906
- **DRUG:** TAK-906 Placebo

## Key facts

- **NCT ID:** NCT03237156
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-07
- **Primary completion:** 2017-10-07
- **Final completion:** 2017-10-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03237156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03237156, "Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03237156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*